首页> 外文期刊>Journal of Medical Case Reports >A novel PTCH1 germline mutation distinguishes basal cell carcinoma from basaloid follicular hamartoma: a case report
【24h】

A novel PTCH1 germline mutation distinguishes basal cell carcinoma from basaloid follicular hamartoma: a case report

机译:一种新型的PTCH1种系突变将基底细胞癌与基底膜滤泡性错构瘤区分开:病例报告

获取原文
获取外文期刊封面目录资料

摘要

Introduction Nevoid basal cell carcinoma syndrome is a rare autosomal dominant disorder characterized by numerous basal cell carcinomas, odontogenic keratocysts of the jaws and developmental defects. The disorder results from mutations in the PTCH1 gene. Case presentation A 15-year-old boy presented to our dental clinic with multiple jaw cysts. The patient had broad confluent eyebrows, a broad base of the nose, frontal bossing and palmoplantar pits. Examination of the jaw cysts revealed many keratinizing cysts without granular cell layers a finding that raised the suspicion of nevoid basal cell carcinoma. Radiological examinations showed calcification of the falx cerebri, spina bifida, bifid thoracic ribs and frontal bossing. Histopathological examination showed basaloid proliferation in the upper dermis with follicular differentiation surrounded by a loose mucinous stroma and retraction artifacts. These features make it difficult to differentiate between nevoid basal cell carcinoma and basaloid follicular hamartoma, especially the presence of these findings on a non-hairy area. BCL-2 staining was positive in the periphery of the basaloid proliferation, which is typical of basaloid follicular hamartoma, and not in a diffuse pattern, which is typical of nevoid basal cell carcinoma. The proband's siblings and parents were healthy with no family history of this condition in the extended family. Since histology was equivocal and palmoplantar pits are seen in both basaloid follicular hamartoma and nevoid basal cell carcinoma, molecular genetic investigation was necessary to differentiate between the two potential diagnoses. After sequencing the entire PTCH1 gene, we detected a single nucleotide deletion (c.1291delC) in codon 431 of the PTCH protein, which resulted in a premature stop translation at residue 431. This de novo mutation was not detected in both parents and in 100 normal volunteers of matching ethnicity. Conclusion Screening the PTCH1 gene for mutations helped to differentiate between basaloid follicular hamartoma and nevoid basal cell carcinoma and confirmed the diagnosis.
机译:引言Nevoid基底细胞癌综合征是一种罕见的常染色体显性遗传疾病,其特征是许多基底细胞癌,颌骨牙源性角膜囊肿和发育缺陷。该疾病是由PTCH1基因突变引起的。病例介绍一名15岁男孩因多颌骨囊肿出现在我们的牙科诊所。该患者有宽大的汇合眉毛,宽阔的鼻子,额突和掌plant凹坑。颌骨囊肿的检查发现许多角质化囊肿没有颗粒状细胞层,这一发现引起了人们对无基底细胞癌的怀疑。放射学检查显示大脑小脑钙化,脊柱裂,双歧性胸肋骨和额突。组织病理学检查显示基底层中基底层增生,并有卵泡分化,周围有疏松的粘液基质和牵拉伪影。这些特征使得难以区分是在无基底细胞癌还是基底膜滤泡状错构瘤,特别是在非毛发区域存在这些发现。 BCL-2染色在基底样增生的周围是阳性的,这是基底样滤泡错构瘤的典型特征,而不是呈弥漫性模式,这是无基底细胞癌的典型特征。先证者的兄弟姐妹和父母都很健康,在大家庭中没有这种情况的家族史。由于组织学模棱两可,并且在基底样滤泡错构瘤和无基底细胞癌中均可见掌凹坑,因此有必要进行分子遗传学研究以区分这两种潜在的诊断。对整个PTCH1基因进行测序后,我们在PTCH蛋白的431位密码子中检测到单核苷酸缺失(c.1291delC),这导致在431位残基处过早停止翻译。在两个亲本和100个亲本中均未检测到这种从头突变种族匹配的普通志愿者。结论筛选PTCH1基因突变有助于区分基底膜滤泡型错构瘤和未发生基底细胞癌,并证实了诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号